Alexion Pharmaceuticals Inc. (ALXN) Revises Upward 2014 Financial Guidance For Revenues And Non-GAAP EPS
3/10/2014 6:33:54 AM
Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) today announced that it is revising upward its previously provided 2014 financial guidance for net product sales and non-GAAP earnings per share (EPS).
The Company will record increased revenue in 2014 related to an agreement that brings to conclusion discussions with the French government and which positively impacts prospective reimbursement of Soliris. The agreement also provides reimbursement for shipments of Soliris made prior to January 1, 2014.
Help employers find you! Check out all the jobs and post your resume.
comments powered by